Patients' survival outcomes in clinical stage IA lung adenocarcinoma not affected by preoperative staging brain magnetic resonance imaging.

ABSTRACT:

Background

The necessity of conducting preoperative staging brain magnetic resonance imaging (MRI) for patients diagnosed with clinical stage IA lung adenocarcinoma (LUAD) is still a topic of discussion. The objective of this study was to explore the impact of staging brain MRI on survival outcomes in patients with clinical stage IA LUAD.

Methods

Patients diagnosed with clinical stage IA LUAD who received curative surgical treatment from May 2005 to December 2018 was selected for this analysis. To account for potential confounding variables, propensity score matching (PSM) was utilized. Survival outcomes including overall survival (OS) over a period of 10 years, 10-year recurrence-free survival (RFS), and 10-year brain metastasis-specific RFS were evaluated. Multivariate Cox

SUBMITTER: Liu M 

PROVIDER: S-EPMC12541873 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature